Related references
Note: Only part of the references are listed.Models of mania: from facets to domains and from animal models to model animals
S. Flaisher-Grinberg et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2010)
GSK3 Influences Social Preference and Anxiety-Related Behaviors during Social Interaction in a Mouse Model of Fragile X Syndrome and Autism
Marjelo A. Mines et al.
PLOS ONE (2010)
Validation and pharmacological characterisation of MK-801-induced locomotor hyperactivity in BALB/C mice as an assay for detection of novel antipsychotics
Andrea M. Bradford et al.
PSYCHOPHARMACOLOGY (2010)
Akt/GSK3 Signaling in the Action of Psychotropic Drugs
Jean-Martin Beaulieu et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY (2009)
Antipsychotic agents in the treatment of bipolar mania
Mauricio Tohen et al.
BIPOLAR DISORDERS (2009)
Attenuation of high sweet solution preference by mood stabilizers: A possible mouse model for the increased reward-seeking domain of mania
Shlomit Flaisher-Grinberg et al.
JOURNAL OF NEUROSCIENCE METHODS (2009)
A possible utilization of the mice forced swim test for modeling manic-like increase in vigor and goal-directed behavior
Shlomit Flaisher-Grinberg et al.
JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS (2009)
Locomotor reactivity to a novel environment and sensitivity to MK-801 in five strains of mice
Mikhail Kalinichev et al.
BEHAVIOURAL PHARMACOLOGY (2008)
Kinases as drug targets in the treatment of bipolar disorder
Lisa A. Catapano et al.
DRUG DISCOVERY TODAY (2008)
Looking at Lithium: Molecular Moods and Complex Behaviour
Jean-Martin Beaulieu et al.
MOLECULAR INTERVENTIONS (2008)
Role of GSK3β in behavioral abnormalities induced by serotonin deficiency
Jean-Martin Beaulieu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Efficacy of small-molecule glycogen synthase kinase-3 inhibitors in the postnatal rat model of tau hyperphosphorylation
M-L Selenica et al.
BRITISH JOURNAL OF PHARMACOLOGY (2007)
Strain differences in lithium attenuation of d-amphetamine-induced hyperlocomotion:: A mouse model for the genetics of clinical response to lithium
Todd D. Gould et al.
NEUROPSYCHOPHARMACOLOGY (2007)
The armamentarium of treatments for bipolar disorder: a review of the literature
David A. Cousins et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2007)
Anxiety-like and exploratory behaviors of isolation-reared mice in the staircase test
Yukio Ago et al.
JOURNAL OF PHARMACOLOGICAL SCIENCES (2007)
Viewpoint -: How can drug discovery for psychiatric disorders be improved?
Yves Agid et al.
NATURE REVIEWS DRUG DISCOVERY (2007)
Regulation of mouse brain glycogen synthase kinase-3 by atypical antipsychotics
Xiaohua Li et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2007)
Animal models of bipolar disorder and mood stabilizer efficacy: A critical need for improvement
Todd D. Gould et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2007)
Different behaviors and different strains: Potential new ways to model bipolar disorder
Haim Einat
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2007)
Schizophrenia as a GSK-3 dysregulation disorder
Simon Lovestone et al.
TRENDS IN NEUROSCIENCES (2007)
Acute bipolar mania: a systematic review and meta-analysis of co-therapy vs. monotherapy
L. A. Smith et al.
ACTA PSYCHIATRICA SCANDINAVICA (2007)
Targeting glycogen synthase kinase-3 in the CNS: Implications for the development of new treatments for mood disorders
Todd D. Gould et al.
CURRENT DRUG TARGETS (2006)
Efficacy of olanzapine and haloperidol in an animal model of mania
Rif S. El-Mallakh et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2006)
Transgenic mice overexpressing glycogen synthase kinase 3β:: A putative model of hyperactivity and mania
Jos Prickaerts et al.
JOURNAL OF NEUROSCIENCE (2006)
Toward constructing an endophenotype strategy for bipolar disorders
Gregor Hasler et al.
BIOLOGICAL PSYCHIATRY (2006)
Targeting glycogen synthase kinase-3 as an approach to develop novel mood-stabilising medications
Todd D. Gould
EXPERT OPINION ON THERAPEUTIC TARGETS (2006)
Modelling facets of mania - new directions related to the notion of endophenotypes
Haim Einat
JOURNAL OF PSYCHOPHARMACOLOGY (2006)
Valproate attenuates dextroamphetamine-induced subjective changes more than lithium
MC Willson et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2005)
An investigation of the efficacy of mood stabilizers in rodent models of prepulse inhibition
JC Ong et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2005)
Ziprasidone in acute bipolar mania - A 21-day randomized, double-blind, placebo-controlled replication trial
SG Potkin et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2005)
An Akt/β-arrestin 2/PP2A signaling complex mediates dopaminergic neurotransmission and behavior
JM Beaulieu et al.
CELL (2005)
Role that phosphorylation of GSK3 plays in insulin
EJ McManus et al.
EMBO JOURNAL (2005)
Evaluation of the effects of lamotrigine, valproate and carbamazepine in a rodent model of mania
R Arban et al.
BEHAVIOURAL BRAIN RESEARCH (2005)
Lithium and valproate attenuate dextroamphetamine-induced changes in brain activation
EC Bell et al.
HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL (2005)
Rapid antidepressive-like activity of specific glycogen synthase kinase-3 inhibitor and its effect on β-catenin in mouse hippocampus
O Kaidanovich-Beilin et al.
BIOLOGICAL PSYCHIATRY (2004)
Lithium antagonizes dopamine-dependent behaviors mediated by an AKT/glycogen synthase kinase 3 signaling cascade
JM Beaulieu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
In vivo evidence that genetic background controls impulse-dependent dopamine release induced by amphetamine in the nucleus accumbens
R Ventura et al.
JOURNAL OF NEUROCHEMISTRY (2004)
Convergent evidence for impaired AKT1-GSK3β signaling in schizophrenia
ES Emamian et al.
NATURE GENETICS (2004)
In vivo regulation of glycogen synthase kinase-3β (GSK3β) by serotonergic activity in mouse brain
XH Li et al.
NEUROPSYCHOPHARMACOLOGY (2004)
Glycogen synthase kinase-3β haploinsufficiency mimics the behavioral and molecular effects of lithium
WT O'Brien et al.
JOURNAL OF NEUROSCIENCE (2004)
AR-A014418, a selective GSK-3 inhibitor, produces antidepressant-like effects in the forced swim test
TD Gould et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2004)
The feasibility of neuropsychological endophenotypes in the search for genes associated with bipolar affective disorder
DC Glahn et al.
BIPOLAR DISORDERS (2004)
Ziprasidone in the treatment of acute bipolar mania: A three-week, placebo-controlled, double-blind, randomized trial
PE Keck et al.
AMERICAN JOURNAL OF PSYCHIATRY (2003)
The endophenotype concept in psychiatry: Etymology and strategic intentions
II Gottesman et al.
AMERICAN JOURNAL OF PSYCHIATRY (2003)
Valproate attenuates hyperactive and perseverative behaviors in mutant mice with a dysregulated dopamine system
RJ Ralph-Williams et al.
BIOLOGICAL PSYCHIATRY (2003)
Olanzapine versus haloperidol in the treatment of acute mania: clinical outcomes, health-related quality of life and work status
L Shi et al.
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY (2002)
Efficacy of olanzapine in combination with valproate or lithium in the treatment of mania in patients partially nonresponsive to valproate or lithium monotherapy
M Tohen et al.
ARCHIVES OF GENERAL PSYCHIATRY (2002)
Hyperactivity and impaired response habituation in hyperdopaminergic mice
XX Zhuang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Brain SPECT imaging of amphetamine-induced dopamine release in euthymic bipolar disorder patients
A Anand et al.
AMERICAN JOURNAL OF PSYCHIATRY (2000)
Efficacy of olanzapine in acute bipolar mania - A double-blind, placebo-controlled study
M Tohen et al.
ARCHIVES OF GENERAL PSYCHIATRY (2000)
Share Paper
